Thailand ALS Patient Registry
Official title: A Prospective, Multicenter Registry Study of Amyotrophic Lateral Sclerosis in Thailand
Run by Chulalongkorn University · NCT07175935 · Data updated 2026-11-12
This registry will collect detailed clinical, genetic, and outcome information from adults with ALS across Thailand to track disease progression and treatment results.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Chulalongkorn University Academic / other |
| Locations | 1 site (Pathum Wan, Bangkok) |
| Status | Recruiting |
| Started | March 1, 2025 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | September 16, 2025 |
| Trial ID | NCT07175935 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (age ≥18) with a diagnosis of ALS by El Escorial or Gold Coast criteria who are willing and able to provide informed consent and receive care at participating Thai centers are ideal candidates.
✕Probably not a fit
Patients who decline consent, who have alternative diagnoses that mimic ALS, or who expect direct access to experimental treatments should not expect clinical benefit from registry participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, observational, multicenter registry will enroll adults diagnosed with ALS at major academic hospitals and neuromuscular centers in Thailand and follow them longitudinally using standardized assessments. Data collected will include ALSFRS-R scores, staging systems (King, MiTos, 9-point), motor and respiratory function tests, quality-of-life measures, cognitive and behavioral evaluations, genetic profiles, and treatments received. All data will be entered into a secure REDCap database with protections under Thai PDPA and international standards. No experimental interventions are provided; the registry is intended to define epidemiology and natural history and to serve as a platform for future clinical and translational research.
Why it matters
Potential benefit: If successful, the registry could improve understanding of ALS in Thailand, help optimize patient care, and make it easier to run future clinical trials locally.
How similar studies have gone: National and international ALS registries have previously yielded important epidemiological, genetic, and natural-history insights, so the registry approach is established though large-scale Thai data are currently lacking.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of ALS according to El Escorial or Gold Coast criteria * Age ≥ 18 years * Ability and willingness to provide informed consent Exclusion Criteria: * Patients unwilling to provide informed consent * Patients with alternative diagnoses mimicking ALS
Where it's running
-
King Chulalongkorn Memorial hospital, The Thai Red Cross Society
Pathum Wan, Bangkok, Thailand Recruiting
Study contacts
- Study coordinator: Jakkrit Amornvit, MD
- Email: jakkrit.a@chula.ac.th
- Phone: +66622169338
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tongue-strengthening exercises for people with ALS
This program will test whether daily tongue-strengthening exercises can help people with ALS maintain or improve speech and swallowing.
-
Registering medical data and care outcomes for ALS, SMA, and other motor disorders
This registry slowly collects routine-care information from adults with ALS, SMA, or other motor disorders to see how they’re treated and how care affects outcomes.
-
Imaging markers for bulbar involvement in inclusion body myositis among IBM and comparison groups
This study tests whether ultrasound and MRI can detect swallowing and bulbar muscle problems in people with inclusion body myositis.
-
7T MRI Pilot to Find Imaging Biomarkers in ALS and related motor neuron diseases
A 7T MRI study is being done to see if ultra-high-field brain scans can reveal non-invasive biomarkers in adults with motor neuron disease, including ALS.
-
Biomarker Repository for Age-Related and Inherited Neurodegenerative Diseases
This study collects blood and genetic samples from people with neurodegenerative diseases and their families to build a shared resource for studying disease risk and biology.
-
Ultra-high-resolution PET imaging of aging, neurodegeneration, and psychotic disorders
We will test whether ultra-high-resolution PET and 3T MRI scans can reveal early brain and spinal cord changes in healthy adults and people with Alzheimer's, Parkinson's disease, ALS, PSP, REM sleep behavior disorder, or psychotic disorders.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.